MedPath

Early withdrawal of phenobarbitone in Neonatal seizures

Not Applicable
Conditions
Health Condition 1: G988- Other disorders of nervous system
Registration Number
CTRI/2019/01/017313
Lead Sponsor
PGIMER Chandigarh
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Neonate >=34weeks of gestation to <28days of postnatal period admitted with neonatal seizure.

Exclusion Criteria

Neonates on >=2 antiepileptic drugs

HIE stage III

Metabolic causes of seizures like hypocalcemia, hypoglycemia

Intracranial bleed

Neonates with brain infarct

Major congenital malformation

Suspected storage disorders

Suspected IEM

Suspected chromosomal anomalies

Suspected intrauterine infections (IUI)

Seizure recurrence within 12 hours of phenobarbitone loading

<34 weeks of gestation

>28 days of postnatal life

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath